Functional Attributes of Antibodies, Effector Cells, and Target Cells Affecting NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity.
Antibodies, Monoclonal
/ immunology
Antibody Specificity
/ immunology
Antibody-Dependent Cell Cytotoxicity
Antigens
/ immunology
Biomarkers
Erythrocytes
/ immunology
Glycosylation
Humans
Immunoglobulin G
/ immunology
Immunophenotyping
Killer Cells, Natural
/ immunology
Models, Biological
Protein Binding
Receptors, IgG
/ metabolism
Journal
Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R
Informations de publication
Date de publication:
15 12 2019
15 12 2019
Historique:
received:
14
08
2019
accepted:
04
10
2019
pubmed:
22
11
2019
medline:
27
5
2020
entrez:
22
11
2019
Statut:
ppublish
Résumé
Ab-dependent cellular cytotoxicity (ADCC) is one of the most important effector mechanisms of tumor-targeting Abs in current immunotherapies. In ADCC and other Ab-dependent activation of myeloid effector cells, close cell-cell contact (between effector and target cell) and formation of immunological synapses are required. However, we still lack basic knowledge on the principal factors influencing ADCC potential by therapeutic Abs. In this study we investigated the combined roles of five factors affecting human NK cell-mediated ADCC, namely: 1) Ag density, 2) target cell membrane composition, 3) IgG FcγR polymorphism, 4) FcγR-blocking cytophilic Abs, and 5) Ab fucosylation. We demonstrate that the magnitude of NK cell-mediated ADCC responses is predominantly influenced by Ag density and Ab fucosylation. Afucosylation consistently induced efficient ADCC, even at very low Ag density, where fucosylated target Abs did not elicit ADCC. On the side of the effector cell, the FcγRIIIa-Val/Phe158 polymorphism influenced ADCC potency, with NK cells expressing the Val158 variant showing more potent ADCC. In addition, we identified the sialic acid content of the target cell membrane as an important inhibitory factor for ADCC. Furthermore, we found that the presence and glycosylation status of aspecific endogenous Abs bound to NK cell FcγRIIIa (cytophilic Abs) determine the blocking effect on ADCC. These five parameters affect the potency of Abs in vitro and should be further tested as predictors of in vivo capacity.
Identifiants
pubmed: 31748349
pii: jimmunol.1900985
doi: 10.4049/jimmunol.1900985
doi:
Substances chimiques
Antibodies, Monoclonal
0
Antigens
0
Biomarkers
0
Immunoglobulin G
0
Receptors, IgG
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3126-3135Informations de copyright
Copyright © 2019 by The American Association of Immunologists, Inc.